We are live on ! Find out more
KXA

KPCB XIII Associates Portfolio holdings

AUM $186M Turnover 0%
1-Year Est. Return 11.23%
This Fund
S&P 500
This Quarter Est. Return
-14.87%
1 Year Est. Return
-11.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
-$38M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
2 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.3 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.5%
2 Technology 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PGNY icon
1
Progyny
PGNY
$2.14B
$173M 92.97%
5,074,615
– –
2020 Q4
11 quarters
LUNG icon
2
Pulmonx
LUNG
$75.2M
$10.3M 5.53%
994,971
– –
2020 Q4
11 quarters
MVLA
3
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$2.78M 1.5%
5,189,011
– –
2023 Q1
2 quarters

Similar funds

KPCB XIII Associates's Q3 2023 Portfolio in Review

As of Q3 2023, KPCB XIII Associates held 3 positions worth $186M, down 17% from $224M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. KPCB XIII Associates opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 95% a quarter earlier, followed by Technology.

  • KPCB XIII Associates's ten largest holdings make up 100% of its $186M portfolio in Q3 2023.
  • KPCB XIII Associates opened 0 new positions and closed 0 in Q3 2023.
  • KPCB XIII Associates's portfolio value fell 17% quarter-over-quarter to $186M.

Based on KPCB XIII Associates's 13F filing for Q3 2023, filed 8 Nov 2023.